ASHLEY FITZPATRICK: Open Payments
NPI 1265831341 · BASALT, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 11 payments from 7 companies in 2025. Trend: 2023 $145 · 2024 $236 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $81 |
| Amgen Inc. | 2 | $44 |
| Abbott Laboratories | 2 | $40 |
| Novo Nordisk Inc | 1 | $26 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
| Exact Sciences Corporation | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: VRAYLAR, QULIPTA, Wegovy, MITRACLIP, UBRELVY, JOURNAVX, EVENITY, Cologuard Collection Kit.
Industry payments across CO — which companies pay providers there.
